Quantifying the hidden healthcare cost of diabetes mellitus in Australian hospital patients

Amalia Karahalios, Gowri Somarajah, Peter S. Hamblin, Harin Karunajeewa, Edward D. Janus

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Background: Diabetes mellitus in hospital inpatients is most commonly present as a comorbidity rather than as the primary diagnosis. In some hospitals, the prevalence of comorbid diabetes mellitus across all inpatients exceeds 30%, which could add to complexity of care and resource utilisation. However, whether and to what extent comorbid diabetes mellitus contributes indirectly to greater hospitalisation costs is ill-defined. Aim: To determine the attributable effect of comorbid diabetes mellitus on hospital resource utilisation in a General Internal Medical service in Melbourne, Australia. Methods: We extracted data from a database of all General Internal Medical discharge episodes from July 2012 to June 2013. We fitted multivariable regression models to compare patients with diabetes mellitus to those without diabetes mellitus with respect to hospitalisation cost, length of stay, admissions per year and inpatient mortality. Results: Of 4657 patients 1519 (33%) had diabetes mellitus, for whom average hospitalisation cost (AUD9910) was higher than those without diabetes mellitus (AUD7805). In multivariable analysis, this corresponded to a 1.22-fold (95% confidence interval (CI) 1.12–1.33, P < 0.001) higher cost. Mean length of stay for those with diabetes was 8.2 days versus 6.8 days for those without diabetes, with an adjusted 1.19-fold greater odds (95% CI 1.06–1.33, P = 0.001) of staying an additional day. Number of admissions and mortality were similar. Conclusion: Comorbid diabetes mellitus adds significantly to hospitalisation duration and costs in medical inpatients. Moreover, diabetes mellitus patients with chronic complications had a greater-still cost and hospitalisation duration compared to those without diabetes mellitus.

Original languageEnglish
Pages (from-to)286-292
Number of pages7
JournalInternal Medicine Journal
Volume48
Issue number3
DOIs
Publication statusPublished - 1 Mar 2018
Externally publishedYes

Keywords

  • adult diabetes mellitus
  • cost
  • healthcare use

Cite this

Karahalios, Amalia ; Somarajah, Gowri ; Hamblin, Peter S. ; Karunajeewa, Harin ; Janus, Edward D. / Quantifying the hidden healthcare cost of diabetes mellitus in Australian hospital patients. In: Internal Medicine Journal. 2018 ; Vol. 48, No. 3. pp. 286-292.
@article{1dcd1a56489b4c6f9feb6478053de3c7,
title = "Quantifying the hidden healthcare cost of diabetes mellitus in Australian hospital patients",
abstract = "Background: Diabetes mellitus in hospital inpatients is most commonly present as a comorbidity rather than as the primary diagnosis. In some hospitals, the prevalence of comorbid diabetes mellitus across all inpatients exceeds 30{\%}, which could add to complexity of care and resource utilisation. However, whether and to what extent comorbid diabetes mellitus contributes indirectly to greater hospitalisation costs is ill-defined. Aim: To determine the attributable effect of comorbid diabetes mellitus on hospital resource utilisation in a General Internal Medical service in Melbourne, Australia. Methods: We extracted data from a database of all General Internal Medical discharge episodes from July 2012 to June 2013. We fitted multivariable regression models to compare patients with diabetes mellitus to those without diabetes mellitus with respect to hospitalisation cost, length of stay, admissions per year and inpatient mortality. Results: Of 4657 patients 1519 (33{\%}) had diabetes mellitus, for whom average hospitalisation cost (AUD9910) was higher than those without diabetes mellitus (AUD7805). In multivariable analysis, this corresponded to a 1.22-fold (95{\%} confidence interval (CI) 1.12–1.33, P < 0.001) higher cost. Mean length of stay for those with diabetes was 8.2 days versus 6.8 days for those without diabetes, with an adjusted 1.19-fold greater odds (95{\%} CI 1.06–1.33, P = 0.001) of staying an additional day. Number of admissions and mortality were similar. Conclusion: Comorbid diabetes mellitus adds significantly to hospitalisation duration and costs in medical inpatients. Moreover, diabetes mellitus patients with chronic complications had a greater-still cost and hospitalisation duration compared to those without diabetes mellitus.",
keywords = "adult diabetes mellitus, cost, healthcare use",
author = "Amalia Karahalios and Gowri Somarajah and Hamblin, {Peter S.} and Harin Karunajeewa and Janus, {Edward D.}",
year = "2018",
month = "3",
day = "1",
doi = "10.1111/imj.13685",
language = "English",
volume = "48",
pages = "286--292",
journal = "Internal Medicine Journal",
issn = "1444-0903",
publisher = "Wiley-Blackwell",
number = "3",

}

Quantifying the hidden healthcare cost of diabetes mellitus in Australian hospital patients. / Karahalios, Amalia; Somarajah, Gowri; Hamblin, Peter S.; Karunajeewa, Harin; Janus, Edward D.

In: Internal Medicine Journal, Vol. 48, No. 3, 01.03.2018, p. 286-292.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Quantifying the hidden healthcare cost of diabetes mellitus in Australian hospital patients

AU - Karahalios, Amalia

AU - Somarajah, Gowri

AU - Hamblin, Peter S.

AU - Karunajeewa, Harin

AU - Janus, Edward D.

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Background: Diabetes mellitus in hospital inpatients is most commonly present as a comorbidity rather than as the primary diagnosis. In some hospitals, the prevalence of comorbid diabetes mellitus across all inpatients exceeds 30%, which could add to complexity of care and resource utilisation. However, whether and to what extent comorbid diabetes mellitus contributes indirectly to greater hospitalisation costs is ill-defined. Aim: To determine the attributable effect of comorbid diabetes mellitus on hospital resource utilisation in a General Internal Medical service in Melbourne, Australia. Methods: We extracted data from a database of all General Internal Medical discharge episodes from July 2012 to June 2013. We fitted multivariable regression models to compare patients with diabetes mellitus to those without diabetes mellitus with respect to hospitalisation cost, length of stay, admissions per year and inpatient mortality. Results: Of 4657 patients 1519 (33%) had diabetes mellitus, for whom average hospitalisation cost (AUD9910) was higher than those without diabetes mellitus (AUD7805). In multivariable analysis, this corresponded to a 1.22-fold (95% confidence interval (CI) 1.12–1.33, P < 0.001) higher cost. Mean length of stay for those with diabetes was 8.2 days versus 6.8 days for those without diabetes, with an adjusted 1.19-fold greater odds (95% CI 1.06–1.33, P = 0.001) of staying an additional day. Number of admissions and mortality were similar. Conclusion: Comorbid diabetes mellitus adds significantly to hospitalisation duration and costs in medical inpatients. Moreover, diabetes mellitus patients with chronic complications had a greater-still cost and hospitalisation duration compared to those without diabetes mellitus.

AB - Background: Diabetes mellitus in hospital inpatients is most commonly present as a comorbidity rather than as the primary diagnosis. In some hospitals, the prevalence of comorbid diabetes mellitus across all inpatients exceeds 30%, which could add to complexity of care and resource utilisation. However, whether and to what extent comorbid diabetes mellitus contributes indirectly to greater hospitalisation costs is ill-defined. Aim: To determine the attributable effect of comorbid diabetes mellitus on hospital resource utilisation in a General Internal Medical service in Melbourne, Australia. Methods: We extracted data from a database of all General Internal Medical discharge episodes from July 2012 to June 2013. We fitted multivariable regression models to compare patients with diabetes mellitus to those without diabetes mellitus with respect to hospitalisation cost, length of stay, admissions per year and inpatient mortality. Results: Of 4657 patients 1519 (33%) had diabetes mellitus, for whom average hospitalisation cost (AUD9910) was higher than those without diabetes mellitus (AUD7805). In multivariable analysis, this corresponded to a 1.22-fold (95% confidence interval (CI) 1.12–1.33, P < 0.001) higher cost. Mean length of stay for those with diabetes was 8.2 days versus 6.8 days for those without diabetes, with an adjusted 1.19-fold greater odds (95% CI 1.06–1.33, P = 0.001) of staying an additional day. Number of admissions and mortality were similar. Conclusion: Comorbid diabetes mellitus adds significantly to hospitalisation duration and costs in medical inpatients. Moreover, diabetes mellitus patients with chronic complications had a greater-still cost and hospitalisation duration compared to those without diabetes mellitus.

KW - adult diabetes mellitus

KW - cost

KW - healthcare use

UR - http://www.scopus.com/inward/record.url?scp=85042928928&partnerID=8YFLogxK

U2 - 10.1111/imj.13685

DO - 10.1111/imj.13685

M3 - Article

VL - 48

SP - 286

EP - 292

JO - Internal Medicine Journal

JF - Internal Medicine Journal

SN - 1444-0903

IS - 3

ER -